Filing Details
- Accession Number:
- 0001104659-21-142471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 16:05:34
- Reporting Period:
- 2021-11-19
- Accepted Time:
- 2021-11-22 16:05:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1736243 | Acurx Pharmaceuticals Inc. | ACXP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1271123 | P David Luci | C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-19 | 5,200 | $4.80 | 1,008,723 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,083 | Indirect | By spouse |
Common Stock | 35,000 | Indirect | By child |